1. EachPod

Episode 17 – GLP-1 in Type 1 Diabetes: beyond weight loss, towards metabolic therapy?

Author
John Pemberton
Published
Fri 05 Sep 2025
Episode Link
None

Episode 17 – GLP-1 in Type 1 Diabetes: beyond weight loss, towards metabolic therapy?


Guest: Prof. Viral Shah

Host: John Pemberton of The Glucose Never Lies

Description:
GLP-1 and GIP therapies are transforming type 2 diabetes and obesity care. But what about type 1 diabetes?

In this episode, I speak with Professor Viral Shah — a leading clinician–researcher in type 1 diabetes, automated insulin delivery, and incretin therapies. Together we explore:

  • Why people with type 1 diabetes face unique metabolic challenges (peripheral insulin delivery, insulin resistance, excess glucagon).
  • How GLP-1/GIP therapies may help reduce insulin needs, manage weight, smooth post-meal highs, and improve long-term outcomes.
  • The latest evidence from trials in type 1 diabetes and what’s on the horizon with dual and triple agonists.
  • Practical questions for people with T1D and healthcare professionals: insulin adjustment, titration, safety, and off-label prescribing.

🔗 Episode show notes & links:
https://theglucoseneverlies.com/glp1-t1d/

🌐 Key Links

The Glucose Never Lies®:

Viral Shah:

Background Reading (GNL):

Enjoy

Share to: